Integrated Biopharma (INBP) EBITDA Margin (2010 - 2026)
Integrated Biopharma's EBITDA Margin came in at -8.16% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 12.81 percentage points from 4.66% a year earlier but up 1.91 percentage points from the prior quarter.
Powered by 
Analysis
Integrated Biopharma (INBP) EBITDA Margin (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma's EBITDA Margin was -5.50%, down 9.80 percentage points from FY2025.
- EBITDA Margin carries a five-year change of -15.13 percentage points (FY2021 to FY2026).
- Going back by fiscal year, EBITDA Margin was 4.30% in FY2025 (+3.19 pp), 1.11% in FY2024 (+0.18 pp), 0.93% in FY2023 (-4.55 pp) and 5.48% in FY2022 (-4.15 pp).
- The five-year range for quarterly EBITDA Margin is -10.06% (fiscal Q3 2026) to 6.88% (fiscal Q3 2022).
- Year-over-year, EBITDA Margin has declined for four consecutive quarters, with an average year-over-year change of -3.46 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q2 2025 (a gain of 5.51 percentage points), and the weakest in fiscal Q3 2026 (a drop of 15.93 percentage points).
- Business Quant data shows INBP's EBITDA Margin at -10.06% (Q3 2026), -7.41% (Q2 2026) and 1.89% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 22.46% |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 21.84% |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | 4.38% |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 21.34% |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 19.10% |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 25.03% |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 28.34% |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 26.81% |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 18.01% |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | -8.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.16% |
| Mar 31, 2026 | -10.06% |
| Dec 31, 2025 | -7.41% |
| Sep 30, 2025 | 1.89% |
| Jun 30, 2025 | 4.66% |
| Mar 31, 2025 | 5.87% |
| Dec 31, 2024 | 2.26% |
| Sep 30, 2024 | 4.22% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 3.29% |
| Dec 31, 2023 | -3.25% |
| Sep 30, 2023 | 0.18% |
| Jun 30, 2023 | 1.25% |
| Mar 31, 2023 | 0.99% |
| Dec 31, 2022 | 0.49% |
| Sep 30, 2022 | 0.96% |
| Jun 30, 2022 | 3.97% |
| Mar 31, 2022 | 6.88% |
| Dec 31, 2021 | 5.54% |
| Sep 30, 2021 | 5.25% |
API Access
Integrated Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();